Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Clinical trial NCT04931823 · TERMINATED
Trial details
- NCT number
- NCT04931823
- Sponsor
- Conjupro Biotherapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-24
- Primary completion
- 2024-08-26
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.